Hysteroscopy and contraception

Veersema, Sebastiaan

doi:10.1016/j.bpobgyn.2015.03.013

Cited by 10 publications

(10 citation statements)

References 60 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…( 5 ) Pain is the main concern of patients, we used the same approach described by Veersema, which is previously inform that discomfort would be similar to menstrual cramps, this information helped patients to become less concerned. ( 2 )…”

Section: Discussionmentioning

confidence: 99%

“…In developing countries the minilaparotomy remains the most common procedure, but in developed countries interval laparoscopic sterilization is most the common technique. ( 2 )…”

Section: Introductionmentioning

confidence: 99%

“…( 5 ) Veersema reports success in placement of 95% to 99% of cases at outpatient unit. ( 2 ) Complications associated with the method are quite rare and include inadequate placement (poor placement), device migration, unintended pregnancies, pain, infection and nickel allergy. Uterine or tubal perforation can result in pregnancy or chronic pelvic pain.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Initial experience with hysteroscopic tubal occlusion (Essure®)

Depes

Pereira

Lippi

et al. 2016

Einstein (São Paulo)

View full text Add to dashboard Cite

Objective To evaluate results of early tubal occlusions performed by hysteroscopy (Essure®). Methods This prospective study included 38 patients, 73.7% of them were white, mean age 34.5 years, they have had on average 3 pregnancies and 2.7 of deliveries. A total of 86.8% of patients previously prepared the endometrium. All procedures were carried out at outpatient unit without anesthesia. Results Insertion rate of the device was 100% at a mean time of 4 minutes and 50 seconds. Based on the analogical visual scale, average pain reported was three, and 55.3% of women did not report pain after the procedure. After 3 months, 89.5% of patients were very satisfied with the method. Simple radiographs of the pelvis showed 92.1% of topical devices, and one case of unilateral expulsion had occurred. A four years follow-up did not show failure in the method.Conclusions Tubal occlusion through hysteroscopy at outpatient unit and without anesthesia was a quickly and well-tolerated procedure. No serious complications were seen, the success rate was high, and patients were satisfied.

show abstract

Section: Discussionmentioning

confidence: 99%

“…In developing countries the minilaparotomy remains the most common procedure, but in developed countries interval laparoscopic sterilization is most the common technique. ( 2 )…”

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Initial experience with hysteroscopic tubal occlusion (Essure®)

Depes

Pereira

Lippi

et al. 2016

Einstein (São Paulo)

View full text Add to dashboard Cite

show abstract

“…The morbidity associated with these invasive approaches, however, results from infection risks, complications accompanying general anaesthesia, and difficult patient recovery/rehabilitation. Advances in laparoscopic, or minimally invasive, surgery have mitigated these drawbacks, albeit without eliminating them [1,3]. …”

Section: Introductionmentioning

confidence: 99%

“…Limited to only luminal or internal access to the Fallopian tubes, the general mechanism for permanent sterilization is the damaging of the tubal epithelium and connective tissue, followed by the proliferation of scar tissue that effectively and durably blocks the tubes. Attempts to damage the tubes typically fall into one or more of the following categories: mechanical, thermal, and chemical [3]. While chemical methods, such as sclerosing drugs and agents, have been pursued, they have not yet been translated into the clinic.…”

Section: Introductionmentioning

confidence: 99%

Design, Manufacture, and In vivo Testing of a Tissue Scaffold for Permanent Female Sterilization by Tubal Occlusion

et al. 2018

View full text Add to dashboard Cite

Current FDA-approved permanent female sterilization procedures are invasive and/or require the implantation of non-biodegradable materials. These techniques pose risks and complications, such as device migration, fracture, and tubal perforation. We propose a safe, non-invasive biodegradable tissue scaffold to effectively occlude the Fallopian tubes within 30 days of implantation. Specifically, the Fallopian tubes are mechanically de-epithelialized, and a tissue scaffold is placed into each tube. It is anticipated that this procedure can be performed in less than 30 minutes by an experienced obstetrics and gynaecology practitioner. Advantages of this method include the use of a fully bio-resorbable polymer, low costs, lower risks, and the lack of general anaesthesia. The scaffold devices are freeze-cast allowing for the custom-design of structural, mechanical, and chemical cues through material composition, processing parameters, and functionalization. The performance of the biomaterial and de-epithelialization procedure was tested in an in vivo rat uterine horn model. The scaffold response and tissue-biomaterial interactions were characterized microscopically post-implantation. Overall, the study resulted in the successful fabrication of resilient, easy-to-handle devices with an anisotropic scaffold architecture that encouraged rapid bio-integration through notable angiogenesis, cell infiltration, and native collagen deposition. Successful tubal occlusion was demonstrated at 30 days, revealing the great promise of a sterilization biomaterial.

show abstract

Techniques for the interruption of tubal patency for female sterilisation

Lawrie

Kulier

Nardin

2016

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Low risk population Complaints: Postoperative pain (24 hours) 477 per 1000 544 per 1000 (420 to 706) OR 1.14 (0.88 to 1.48) 922 (3) ⊕⊕⊕⊕ high *The basis for the assumed risk is the median control group (clip) risk across studies. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: confidence interval; OR: odds ratio GRADE Working Group grades of evidence High quality: Further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low quality: We are very uncertain about the estimate.

show abstract

Hysteroscopy and contraception

Cited by 10 publications

References 60 publications

Initial experience with hysteroscopic tubal occlusion (Essure®)

Initial experience with hysteroscopic tubal occlusion (Essure®)

Design, Manufacture, and In vivo Testing of a Tissue Scaffold for Permanent Female Sterilization by Tubal Occlusion

Techniques for the interruption of tubal patency for female sterilisation

Contact Info

Product

Resources

About